Bisphosphonates in rheumatoid arthritis (osteoporosis excluded)
Maillefert, J.F.; Sibilia, J.; Bertin, P.; Tavernier, C.
Revue du Rhumatisme 66(10): 442-445
1999
ISSN/ISBN: 1169-8446 PMID: 10567971 Document Number: 511384
Document emailed within 1 workday
Related Documents
Nagashima, M.; Shu, G.; Yamamoto, K. 2005: Biological effects of bisphosphonates in patients with rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 63(9): 1607-1612Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Suzuki, Y.; Uehara, R.; Ide, M.; Ichikawa, Y. 1998: Osteoporosis in rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 56(6): 1598-1603
Haugeberg, G. 1997: Osteoporosis in rheumatoid arthritis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 117(5): 651-654
Urbanek, R.; Tłustochowicz, W.; Patoła, J.; Głodzik, J. 2000: Incidence of osteoporosis in patients with rheumatoid arthritis Przeglad Lekarski 57(2): 103-107
Sineglazova, A.V. 2013: Coronary atherosclerosis and osteoporosis in rheumatoid arthritis Vestnik Rentgenologii i Radiologii 1: 25-28
Leszczyński, P.; Lacki, J.K.; Mackiewicz, S.H. 2000: Glucocorticosteroid induced osteoporosis in patients with rheumatoid arthritis Przeglad Lekarski 57(2): 108-110
Holovach, I.I. 2002: Effect of rarefaction process on osteoporosis in rheumatoid arthritis Likars'ka Sprava 2002(3-4): 54-57
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Grana, J.; Mahia, I.V.; Meizoso, M.-O.S.; Vazquez, T. 2008: Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis) Clinical and Experimental Rheumatology 26(2): 384-385
Jolles, B.M.; Bogoch, E.R. 2002: Current consensus recommendations for rheumatoid arthritis therapy: a blind spot for osteoporosis prevention and treatment Journal of Rheumatology 29(9): 1814-1817
Furuya, T. 2017: Calcium and bone metabolism across women's life stages. Osteoporosis in female patients with rheumatoid arthritis Clinical Calcium 27(5): 691-698
Shostak, N.A.; Muradiants, A.A.; Kondrashov, A.A.; Denisova, S.N. 2014: Clinical efficacy instant goat milk in the complex therapy and prevention of osteoporosis in patients with rheumatoid arthritis Voprosy Pitaniia 83(5): 79-85
Lange, U.; Illgner, U.; Teichmann, J.; Schleenbecker, H. 2004: Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: a prospective study International Journal of Clinical Pharmacology Research 24(2-3): 33-38
2001: Osteoporosis therapy with bisphosphonates. Once weekly is enough MMW Fortschritte der Medizin 143(44): 58
Homik, J.E.; Cranney, A.; Shea, B.; Tugwell, P.; Wells, G.; Adachi, J.D.; Suarez-Almazor, M.E. 1999: A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis Journal of Rheumatology 26(5): 1148-1157
Furuya, T. 2014: Epidemiology of bone and joint disease - the present and future - . Risk factors for fractures and treatment of osteoporosis in Japanese patients with rheumatoid arthritis Clinical Calcium 24(5): 743-749
Aksaranugraha, S. 2015: BMD Changes Following 2-Year Treatment of Osteoporosis by using BMK to Monitor the Dose of Bisphosphonates Journal of the Medical Association of Thailand 98 Suppl. 8: S8-12
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162